At the news
? NEUTRALIMPACT 2/10 144 filed Sep 15, 2026 at 18:09 ET
Stephen Michael Kelsey, an officer of Revolution Medicines, Inc., filed a Form 144 indicating intent to sell 5,415 shares of common stock, with an estimated aggregate market value of approximately $1,103,414.55. The shares were acquired via RSU vesting on September 15, 2026, and the sale is intended to cover tax withholding obligations related to the vesting. This is a routine, small-scale sale relative to the officer's total holdings and the company's $44B market cap, with no bearish signal.
- Officer Stephen Michael Kelsey filed Form 144 to sell 5,415 shares of RVMD common stock.
- Estimated aggregate market value of the proposed sale is ~$1.1M.
- Shares were acquired via RSU vesting on September 15, 2026, and the sale is for tax withholding purposes.
- Kelsey still holds 92,531 shares of common stock as of September 11, 2026, valued at ~$18.7M.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access